TNFA

TNFA

USD

TNF Pharmaceuticals Inc. Common Stock

$5.200-0.430 (-7.638%)

Precio en Tiempo Real

Tecnología
Hardware de computadora
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$5.630

Máximo

$8.900

Mínimo

$4.200

Volumen

0.52M

Fundamentos de la Empresa

Capitalización de Mercado

9.6M

Industria

Hardware de computadora

País

United States

Estadísticas de Negociación

Volumen Promedio

1.82M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $3.24Actual $5.200Máximo $195

Noticias Relacionadas

BusinessWire

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"

Licensed technology positions Company at forefront of new quantum-class computing paradigm

Ver más
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
BusinessWire

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing

New trading symbol QCLS effective Thursday, September 25, 2025 Licensed technology positions Company at forefront of new quantum-class computing paradigm TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("Q/C" or the

Ver más
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing
BusinessWire

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals Inc. (NASDAQ:TNFA), ("TNF" or the "Company") today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company has regained compliance

Ver más
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
BusinessWire

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Management to present on Wednesday, September 10, 2025, at 8:00 a.m. ET TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company") today announced its participation in the H.C. Wainwright & Co. 27th Annual

Ver más
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.